High-cost, specialty medicines account for an ever-increasing proportion of new treatments coming to market, reveals a n…

New medicines simply won’t be coming to Canada if the government goes ahead with changes to how the Patented Medicines P…

A new report by the Patented Medicine Prices Review Board (PMPRB) reveals that prescription drug expenditures by Canadia…

The federal government announced today the final amendments to the Patented Medicines Regulations which it says will red…

Nearly all of the new medicines entering the market in recent years came with high treatment costs, says a new report by…

The Canadian Life and Health Insurance Association (CLHIA) has set out a list of recommendations that it says will prote…

Public drug plan expenditures increased by 1.9 per cent in 2016-2017, according to the Patented Medicine Prices Review B…